Search

Search Results for "Avastin"

Thumbnail for vj292

Avastin Capsular Damage

Thumbnail for onevi

Avastin and PDR

Yusuke Oshima, MD

Thumbnail for logeq

ROP & Avastin

Carl Claes, MD

Thumbnail for horaz

ROP and Avastin

Carl Claes, MD

Thumbnail for godop

The Safest Treatments For CSC

Michael Koss, MD

Thumbnail for vwfet

Diabetic TRD

Dimitra Skondra, MD, PhD

Thumbnail for odepo

Tractional Retinal Detachment with 27G

Ulrich Spandau

Thumbnail for pusif

CATT Trial Results

Thumbnail for uwenu

ASSESS Study - 24 Months

Rishi P. Singh, MD

Thumbnail for rmnew

Trials on Steroids for Diabetic Eye Disease

Albert J. Augustin, MD

Thumbnail for wtixt

Anti-VEGF Therapy and Vitrectomy in Severe PDR

Protocol AC: Step Therapy in DME thumbnail

Protocol AC: Step Therapy in DME

Chirag D. Jhaveri, MD; and Prof. Ramin Tadayoni

Protocol AC Guides DME Treatment Approaches thumbnail

Protocol AC Guides DME Treatment Approaches

Chirag D. Jhaveri, MD

Thumbnail for dvyak

DEL MAR: Phase 2, Stage 2

David S. Boyer, MD

Switch Case: Massive PED (Part 2) thumbnail

Switch Case: Massive PED (Part 2)

Yasha S. Modi, MD

Switching from Bevacizumab to Aflibercept 8 mg in a Neovascular AMD Patient After Handoff from a Colleague thumbnail

Switching from Bevacizumab to Aflibercept 8 mg in a Neovascular AMD Patient After Handoff from a Colleague

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

Real-World Switch Case: Wet AMD Therapy in a Patient Averse to Injections thumbnail

Real-World Switch Case: Wet AMD Therapy in a Patient Averse to Injections

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

ROP Regression with Anti-VEGF Therapy thumbnail

ROP Regression with Anti-VEGF Therapy

Yuxi Zheng, MD

Real-World Step Therapy Case: A Challenging DME Patient thumbnail

Real-World Step Therapy Case: A Challenging DME Patient

Priya Sharma Vakharia, MD, Joseph M. Coney, MD, and Jordan M. Graff, MD

Switching From Bevacizumab to Aflibercept 8 mg in a Patient With Neovascular AMD thumbnail

Switching From Bevacizumab to Aflibercept 8 mg in a Patient With Neovascular AMD

David Miller, MD; Ehsan Rahimy, MD; and Esther Kim, MD

ARVO '25: Real-World Next-Gen Anti-VEGF Dosing and TKIs in the Pipeline

David Miller, MD; and Robert Wang, MD

View More